A detailed history of Asb Consultores, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Asb Consultores, LLC holds 4,233 shares of ABBV stock, worth $741,494. This represents 0.34% of its overall portfolio holdings.

Number of Shares
4,233
Previous 4,233 -0.0%
Holding current value
$741,494
Previous $726,000 15.01%
% of portfolio
0.34%
Previous 0.26%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $159,743 - $186,544
-1,032 Reduced 19.6%
4,233 $726,000
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $603,799 - $687,973
3,778 Added 254.07%
5,265 $958,000
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $169,523 - $190,923
-1,232 Reduced 45.31%
1,487 $230,000
Q3 2023

Nov 28, 2023

SELL
$133.59 - $154.65 $34,065 - $39,435
-255 Reduced 8.57%
2,719 $405,000
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $38,295 - $47,656
-289 Reduced 8.86%
2,974 $400,000
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $49,167 - $56,623
-340 Reduced 9.44%
3,263 $520,000
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $60,994 - $73,148
-441 Reduced 10.91%
3,603 $582,000
Q3 2022

Jan 11, 2023

BUY
$134.21 - $153.93 $23,084 - $26,475
172 Added 4.44%
4,044 $543,000
Q2 2022

Jan 11, 2023

BUY
$137.62 - $174.96 $66,883 - $85,030
486 Added 14.35%
3,872 $593,000
Q1 2022

Jan 11, 2023

BUY
$131.98 - $163.75 $446,884 - $554,457
3,386 New
3,386 $549,000
Q4 2021

Jan 11, 2023

SELL
$107.43 - $135.93 $217,330 - $274,986
-2,023 Reduced 50.02%
2,021 $274,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Asb Consultores, LLC Portfolio

Follow Asb Consultores, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asb Consultores, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asb Consultores, LLC with notifications on news.